Alabama
Birmingham; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Hoover; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Mobile; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Arizona
Phoenix; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Phoenix; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Phoenix; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Sedona ; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Sedona ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Tucson ; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Tucson ; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Tucson ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
California
Alhambra; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Alhambra; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Anaheim; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Anaheim; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Bakersfield; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Bakersfield; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Bakersfield; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Berkeley; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Campbell; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Colton; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Duarte; City of Hope
A Phase I Trial of Radiommunotherapy (Y90 cT8.66), Gemcitabine and Hepatic Arterial Infusion of Fudr for Metastatic Colorectal Carcinoma to the Liver
Fountain Valley; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Fountain Valley; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Fountain Valley; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Fresno; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Fullerton; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Fullerton; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Gilroy; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Greenbrae; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Greenbrae; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
La Jolla; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
La Jolla; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Loma Linda; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Loma Linda; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Long Beach; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Long Beach; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Los Angeles; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Los Angeles; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Los Angeles; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Los Angeles; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Los Angeles; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Los Angeles; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Modesto; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Modesto; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Montebello; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Northridge; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Northridge; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Orange; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Orange; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Oxnard; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Oxnard; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Pomona; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Pomona; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Redondo Beach; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Sacramento; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Sacramento; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
San Diego ; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
San Diego ; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Santa Barbara; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Santa Barbara; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Santa Maria; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Santa Rosa; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Santa Rosa; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Soquel; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Vallejo; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
Vista; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Vista; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Colorado
Colorado Springs; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Denver; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Denver; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Denver; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Denver; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Fort Collins; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Connecticut
Hartford; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
New Haven; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Norwich; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Norwich; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Stamford; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
Waterbury; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Waterbury; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Waterbury; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
West Haven; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Delaware
Newark; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Florida
Boca Raton; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Boynton Beach; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Brooksville; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Fort Lauderdale; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Gainesville; Gainesville Hematology/ Oncology Associates
A Phase III Study of Chemotherapy and Bevacizumab With and Without Panitumimab in the First Line Treatment of Subjects With Metastatic Colorectal Cancer
Gainesville; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Gainesville; Gainesville Hematology/ Oncology Associates
A Randomized Phase III Trial of Cetuximab, Bevacizumab and Biweekly Infusional 5-FU/Leucovorin (FOLF-CB) versus Oxaliplatin, Bevacizumab, and Biweekly Infusional 5-FU/Leucovorin (Bev-FOLFOX) in First-line Treatment of Metastatic Colorectal Cancer
Jacksonville; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Jacksonville; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Lake City; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Lakeland; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Lakeland; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Melbourne; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Miami; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Miami; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Miami; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Miami; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Miami Shores; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
New Port Richey ; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
New Port Richey ; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
New Port Richey ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
North Miami Beach ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Ocala; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Ocala; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Ocoee ; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Ocoee ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Orlando; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
Vero Beach; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Georgia
Atlanta; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Atlanta; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Atlanta; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Atlanta; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Decatur; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Lawrenceville; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Marietta; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Marietta; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Snellville; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Illinois
Chicago; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Dekalb; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Elmhurst; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Niles; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Niles; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Peoria; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Peoria; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Peoria; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Peoria; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Skokie; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
Indiana
Beech Grove; American Health Network of Indiana LLC, Oncology Division
A Phase I, Open-label, Dose-escalation Trial of Study Drug Administered Intravenously to Patients with Advanced Chronic Lymphocytic Leukemia that is Refractory or Relapsed After Prior Treatment.
Beech Grove; American Health Network of Indiana LLC, Oncology Division
Phase II: First/Second Line if prior tx (adjuvant chemo w/ radiation) > 12 mos.
Indianapolis ; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Indianapolis ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
South Bend; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Terre Haute; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Terre Haute; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Terre Haute; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Kansas
Hutchinson; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Kentucky
Lexington; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Lexington; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Paducah; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Louisiana
Metairie; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
New Orleans; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
New Orleans; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Maine
Bangor; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Scarborough; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Maryland
Baltimore; Johns Hopkins Unv., School of Medicine
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
Baltimore; Johns Hopkins Unv. School of Med., Sidney Kimmel Comprehensive Cancer Center
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
Baltimore; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Baltimore; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Columbia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Columbia; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Massachusetts
Boston; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Boston; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Pittsfield; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Pittsfield; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Worcester; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Worcester; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Michigan
Ann Arbor; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Detroit; Henry Ford Health System
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
Minnesota
Duluth; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Duluth; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Minneapolis; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Robbinsdale; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
St Louis Park; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
St Louis Park; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Missouri
Columbia ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Columbia ; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Kansas City; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
St Joseph; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
St Louis; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
St Louis; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
St Louis; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
St. Louis; Washington University School of Medicine - Barnes Jewish Hospital
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
Montana
Billings; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Billings; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Nebraska
Omaha; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Omaha; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Nevada
Las Vegas; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Las Vegas; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Las Vegas; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Las Vegas; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Las Vegas; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Reno ; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Reno ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
New Hampshire
Hooksett; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Portsmouth; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
New Jersey
East Orange; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Hamilton; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Manasquan; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Morristown; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Neptune; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
New Brunswick; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Summit; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Summit; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
New Mexico
Albuquerque; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Albuquerque; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Albuquerque; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Albuquerque; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Albuquerque; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Albuquerque; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Farmington; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Santa Fe; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Santa Fe; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
New York
Albany; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Albany; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Albany; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Armonk; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Bronx; Biomedical Research Alliance of New York
Colorectal Cancer- Metastatic
Bronx; Biomedical Research Alliance of New York
Colorectal Cancer- radiographic evidence
Brooklyn; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Brooklyn; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Buffalo; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Buffalo; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Great Neck; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Huntington Station; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Huntington Station; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
New Hyde Park; Biomedical Research Alliance of New York
Colorectal Cancer- Metastatic or locally advanced
New York; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
New York; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
New York; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
New York; Mount Sinai Medical Center
An Open-Label, Multi-Center Phase II Trial of Neoadjuvant Irinotecan in Combination with Infusional 5-FU, Leucovorin (FOLFIRI) Plus Bevacizumab in Patients with Unresectable Hepatic-Only Metastases of Colorectal Carcinoma [A5961065]
Nyack; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Rochester; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Rochester; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
South Bronx; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
South Bronx; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Syracuse; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
North Carolina
Charlotte; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Charlotte; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Charlotte; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Charlotte; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Durham; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Durham; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Greensboro; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Greenville; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Hickory ; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Hickory ; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Hickory ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Huntersville; Carolina BioOncology Institute, PLLC
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
Raleigh; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
Wilmington; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Wilmington; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Winston-Salem; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
North Dakota
Bismarck; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Fargo; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Ohio
Boardman; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Canton; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Cincinnati; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Cleveland; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Columbus; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Dayton; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Kettering ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Oregon
Eugene; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Eugene; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Pennsylvania
Bethlehem; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Darby; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Dunmore; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
East Stroudsburg; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Ephrata; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Ephrata; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Kingston ; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Kingston ; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Media; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Philadelphia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Philadelphia; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Philadelphia; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Pittsburgh; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Pittsburgh; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Pittsburgh; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Sayre; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Scranton; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Scranton; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Upland; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
Rhode Island
Providence; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Providence; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
South Carolina
Beaufort; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Charleston; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Charleston; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Columbia; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Columbia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Florence; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Florence; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Mount Pleasant; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Sumter; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Tennessee
Bristol; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Chattanooga; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Cookeville; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Cookeville; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Memphis ; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Memphis ; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Memphis ; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Nashville; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Nashville; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Nashville; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Nashville; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Texas
Abilene; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Amarillo; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Amarillo; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Arlington; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Arlington; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Austin; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Austin; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Bedford; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Bedford; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Carrollton; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Dallas; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Dallas; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Dallas; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Denton; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
El Paso; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Fort Worth; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Fort Worth; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Fort Worth; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Fort Worth; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Fort Worth; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Garland; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Garland; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Houston; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Houston; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Houston; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Houston; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Lewisville; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Lewisville; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Longview ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Lubbock; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Mcallen; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Mesquite; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Mesquite; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Midland; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Odessa; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Paris; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Richardson ; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Round Rock ; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
San Antonio; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
San Antonio; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Sherman; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Sugarland; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Sugarland; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Tyler; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Tyler; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
Waco; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Waco; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Webster; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Utah
Salt Lake City; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Salt Lake City; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Salt Lake City; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Vermont
Burlington; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Burlington; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Colchester; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Colchester; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Virginia
Christiansburg; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
Norfolk ; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Richmond; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Salem; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Washington
Burien; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Burien; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Edmonds; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Seattle; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Seattle; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Spokane ; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Yakima; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Yakima; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Washington, DC
Various Cities; Research Center
Metastatic Colorectal Cancer Study CRAD001C2242
Washington; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
Washington; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Washington; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Washington; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Wisconsin
Madison; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Milwaukee; Research Site:
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
Wausau; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
International
Alger, Algeria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Bahia Blanca, Argentina; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Buenos Aires , Argentina; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Buenos Aires , Argentina; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Córdoba, Argentina; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
La Plata, Argentina; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Rosario, Argentina; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Salta, Argentina; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
San Miguel De Tucuman, Argentina; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Santa Fe, Argentina; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Adelaide, Australia; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Adelaide, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Adelaide, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Adelaide, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Adelaide, Australia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Adelaide, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Bendigo, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Brisbane, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Brisbane, Australia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Brisbane, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Brisbane, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Brisbane, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Darlinghurst, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Fitzroy, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
Fitzroy, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Fitzroy, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Fitzroy, Australia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Fremantle, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Heidelberg, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Kingswood, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Malvern, Australia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Malvern, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Melbourne, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Melbourne, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Melbourne, Australia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Melbourne, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Melbourne, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
Melbourne, Australia; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Melbourne, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Perth, Australia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Perth, Australia; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Perth, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Perth, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Perth, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Port Macquarie, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Port Macquarie, Australia; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Port Macquarie, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Port Macquarie, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
St. Leonards, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
St. Leonards, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
St. Leonards, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Sydney, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
Sydney, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Sydney, Australia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Sydney, Australia; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Sydney, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Sydney, Australia; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Sydney, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Waratah, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Waratah, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Wodonga, Australia; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Wodonga, Australia; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Wollongong, Australia; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Wollongong, Australia; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Graz, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Graz, Austria; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Hall In Tirol, Austria; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Innsbruck, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
Innsbruck, Austria; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Innsbruck, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Klagenfurt, Austria; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Klagenfurt, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Leoben, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Linz, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
Linz, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Oberwart, Austria; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Salzburg, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
Salzburg, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
St Pölten, Austria; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Vöcklabruck, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Wels, Austria; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Wien, Austria; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Wien, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Wien, Austria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
Wien, Austria; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Wien, Austria; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Dhaka, Bangladesh; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Antwerpen, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Arlon, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Brasschaat, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Bruxelles, Belgium; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Bruxelles, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Bruxelles, Belgium; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Bruxelles, Belgium; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Bruxelles, Belgium; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Charleroi, Belgium; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Charleroi, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Edegem, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Genk, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Gent, Belgium; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Gent, Belgium; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Gent, Belgium; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Gent, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Haine-Saint-Paul, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Kortrijk, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Kortrijk, Belgium; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Kortrijk, Belgium; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Leuven, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Leuven, Belgium; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Leuven, Belgium; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Libramont, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Liege, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Mont-Godinne, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Mont-Godinne, Belgium; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Wilrijk, Belgium; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Belo Horizonte, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Belo Horizonte, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Belo Horizonte, Brazil; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Brasilia, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Brasilia, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Campinas, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Campinas, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Caxias do Sul, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Caxias do Sul, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Curitiba, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Curitiba, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Fortaleza, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Fortaleza, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Ijuí, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Ijuí, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Jaú, Brazil; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Jaú, Brazil; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Porto Alegre, Brazil; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Porto Alegre, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Porto Alegre, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Porto Alegre, Brazil; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Recife, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Recife, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Ribeirão Preto, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Ribeirão Preto, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Rio De Janeiro, Brazil; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Rio De Janeiro, Brazil; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Rio De Janeiro, Brazil; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Rio De Janeiro, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Rio De Janeiro, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Salvador, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.
Salvador, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Salvador, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Sao Paulo, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.
Sao Paulo, Brazil; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Sao Paulo, Brazil; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Sao Paulo, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Sao Paulo, Brazil; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Sao Paulo, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Sao Paulo, Brazil; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Sorocaba, Brazil; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.
Sorocaba, Brazil; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Sorocaba, Brazil; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Blagoevgrad, Bulgaria; Research Site:
A Study of Xeloda (Capecitabine) in the Adjuvant Treatment of Patients With Resected Colon Cancer
Plovdiv, Bulgaria; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Plovdiv, Bulgaria; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Ruse, Bulgaria; Research Site:
A Study of Xeloda (Capecitabine) in the Adjuvant Treatment of Patients With Resected Colon Cancer
Shumen, Bulgaria; Research Site:
A Study of Xeloda (Capecitabine) in the Adjuvant Treatment of Patients With Resected Colon Cancer
Sofia, Bulgaria; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Sofia, Bulgaria; Research Site:
A Study of Xeloda (Capecitabine) in the Adjuvant Treatment of Patients With Resected Colon Cancer
Sofia, Bulgaria; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Sofia, Bulgaria; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Stara Zagora, Bulgaria; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Stara Zagora, Bulgaria; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Varna, Bulgaria; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Veliko Tarnovo, Bulgaria; Research Site:
A Study of Xeloda (Capecitabine) in the Adjuvant Treatment of Patients With Resected Colon Cancer
Barrie, ON, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Brampton, ON, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Brampton, ON, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
Brampton, ON, Canada; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Calgary, AB, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
Calgary, AB, Canada; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Calgary, AB, Canada; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Calgary, AB, Canada; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Calgary, AB, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Edmonton, AB, Canada; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Edmonton, AB, Canada; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Edmonton, AB, Canada; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Edmonton, AB, Canada; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Edmonton, AB, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Greenfield Park, QC, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Greenfield Park, QC, Canada; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Halifax, NS, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
Halifax, NS, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Halifax, NS, Canada; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Halifax, NS, Canada; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Halifax, NS, Canada; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Hamilton, ON, Canada; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Hamilton, ON, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
Hamilton, ON, Canada; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Hamilton, ON, Canada; Research Site:
A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.
Kelowna, BC, Canada; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Kelowna, BC, Canada; Research Site:
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Kelowna, BC, Canada; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Kelowna, BC, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Kelowna, BC, Canada; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Kingston, ON, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Kitchener, ON, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Laval, QC, Canada; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Laval, QC, Canada; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Laval, QC, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Levis, QC, Canada; Research Site:
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Levis, QC, Canada; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
Levis, QC, Canada; Research Site:
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Levis, QC, Canada; Research Site:
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Levis, QC, Canada; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
London, ON, Canada; Research Site:
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer
London, ON, Canada; Research Site:
A Study of Xelod
